Survival after radiofrequency ablation and/or chemotherapy for lung cancer and pulmonary metastases: a systematic review and meta-analysis

Survival after radiofrequency ablation and/or chemotherapy for lung cancer and pulmonary metastases: a systematic review and meta-analysis

BackgroundRadiofrequency ablation (RFA) and chemotherapy are used to treat lung cancer or pulmonary metastases, but no direct comparison of overall survival (OS) has been published. The present study aimed to assess the OS of RFA and/or chemotherapy in patients with lung cancer or pulmonary metastas...

Full description

Bibliographic Details
Main Authors: Ziyi Yang, Xia Lyu, Huilin Yang, Bingbing Wang, Dan Xu, Lingyi Huo, Runzi Zhang, Yingjun Huang, Benshu Diao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Immunology
Subjects:
lung cancer
pulmonary metastases
radiofrequency ablation
chemotherapy
systematic review
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1240149/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1240149/full

Similar Items